Eur Rev Med Pharmacol Sci 2021; 25 (4): 1821-1827

DOI: 10.26355/eurrev_202102_25076

Mammary Paget’s disease and radiotherapy: a systematic literature review

A. Piras, L. Boldrini, V. Venuti, A. Sanfratello, M. La Vecchia, R. Gennari, G. Sortino, T. Angileri, A. Daidone

UO Radioterapia Oncologica, Villa Santa Teresa, Bagheria, Palermo, Italy. antoniopiras88@gmail.com


OBJECTIVE: Paget disease of the breast (PDB) is a rare form of cutaneous breast cancer. Up to date, no randomized studies evaluated the different management strategies. This systematic review investigates the role of radiotherapy and its best technical profile in the treatment of this disease, with great attention to doses and fractionation regimens.

MATERIALS AND METHODS: A systematic search was performed on PubMed, Embase and Scopus in order to detect case reports, case series and prospective as well as retrospective clinical studies describing histologically proven PDB and providing information about pertinent radiation treatments. Searching strategy followed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines.

RESULTS: Inclusion criteria were met by six papers, dealing with radiation treatments performed postoperatively and in exclusive settings. No evaluations were performed on preoperative radiotherapy.

CONCLUSIONS: Actually, the standard treatment of PDB reflects oncological principles of breast carcinoma therapy, including the role of breast-preserving surgery. The traditional radiotherapic dose is 50 Gy, with daily fractionation of 2 Gy. Adjuvant radiotherapy following breast preserving surgery represents the current standard of care; prospective studies could be of help in defining the role of exclusive radiotherapy, hypofractionated schemes and smaller target volumes.

Free PDF Download

To cite this article

A. Piras, L. Boldrini, V. Venuti, A. Sanfratello, M. La Vecchia, R. Gennari, G. Sortino, T. Angileri, A. Daidone
Mammary Paget’s disease and radiotherapy: a systematic literature review

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 4
Pages: 1821-1827
DOI: 10.26355/eurrev_202102_25076